U.S. flag

An official website of the United States government

NM_000335.5(SCN5A):c.5589G>T (p.Glu1863Asp) AND not provided

Germline classification:
Uncertain significance (3 submissions)
Last evaluated:
Oct 10, 2023
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000183127.20

Allele description [Variation Report for NM_000335.5(SCN5A):c.5589G>T (p.Glu1863Asp)]

NM_000335.5(SCN5A):c.5589G>T (p.Glu1863Asp)

Gene:
SCN5A:sodium voltage-gated channel alpha subunit 5 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
3p22.2
Genomic location:
Preferred name:
NM_000335.5(SCN5A):c.5589G>T (p.Glu1863Asp)
Other names:
p.E1864D:GAG>GAT
HGVS:
  • NC_000003.12:g.38550780C>A
  • NG_008934.1:g.103893G>T
  • NM_000335.5:c.5589G>TMANE SELECT
  • NM_001099404.2:c.5592G>T
  • NM_001099405.2:c.5538G>T
  • NM_001160160.2:c.5493G>T
  • NM_001160161.2:c.5430G>T
  • NM_001354701.2:c.5535G>T
  • NM_198056.3:c.5592G>T
  • NP_000326.2:p.Glu1863Asp
  • NP_001092874.1:p.Glu1864Asp
  • NP_001092875.1:p.Glu1846Asp
  • NP_001153632.1:p.Glu1831Asp
  • NP_001153633.1:p.Glu1810Asp
  • NP_001341630.1:p.Glu1845Asp
  • NP_932173.1:p.Glu1864Asp
  • NP_932173.1:p.Glu1864Asp
  • LRG_289t1:c.5592G>T
  • LRG_289:g.103893G>T
  • LRG_289p1:p.Glu1864Asp
  • NC_000003.11:g.38592271C>A
  • NM_198056.2:c.5592G>T
Protein change:
E1810D
Links:
dbSNP: rs794728899
NCBI 1000 Genomes Browser:
rs794728899
Molecular consequence:
  • NM_000335.5:c.5589G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001099404.2:c.5592G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001099405.2:c.5538G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001160160.2:c.5493G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001160161.2:c.5430G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001354701.2:c.5535G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_198056.3:c.5592G>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000235538GeneDx
criteria provided, single submitter

(GeneDx Variant Classification Process June 2021)
Uncertain significance
(Nov 19, 2019)
germlineclinical testing

Citation Link,

SCV000815122Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Mar 4, 2023)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV001472776ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
criteria provided, single submitter

(ARUP Molecular Germline Variant Investigation Process 2024)
Uncertain significance
(Oct 10, 2023)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From GeneDx, SCV000235538.15

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

Has not been previously published in association with SCN5A-related disorders; Reported in ClinVar as a variant of uncertain significance (ClinVar Variant ID# 201541; Landrum et al., 2016); No data available from control populations to assess the frequency of this variant; Functional studies do not show that this variant has a significant impact on sodium channel function (Deschenes et al., 2001); In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 11562792)

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Labcorp Genetics (formerly Invitae), Labcorp, SCV000815122.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

This sequence change replaces glutamic acid, which is acidic and polar, with aspartic acid, which is acidic and polar, at codon 1864 of the SCN5A protein (p.Glu1864Asp). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant  is likely to be tolerated. ClinVar contains an entry for this variant (Variation ID: 201541). This variant has not been reported in the literature in individuals affected with SCN5A-related conditions. This variant is present in population databases (rs794728899, gnomAD 0.01%).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories, SCV001472776.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

The SCN5A c.5592G>T, p.Glu1864Asp variant (rs794728899), to our knowledge, is not reported in the medical literature but is in ClinVar (Variation ID: 201541). This variant is only observed on one allele in the Genome Aggregation Database, indicating it is not a common polymorphism. Computational analyses are uncertain whether this variant is neutral or deleterious (REVEL: 0.615). Due to limited information, the clinical significance of the p.Glu1864Asp variant is uncertain at this time.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 3, 2024